A REVIEW OF PHENOBARBITAL SODIUM POWDER

Contraindicated (one)pentobarbital will reduce the level or effect of lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with potent CYP3A4 inducers can lead to lowered serum concentrations and lack of antimalarial efficacypentobarbital will reduce the level or effect of oxybutynin by affecting